96 related articles for article (PubMed ID: 12523085)
1. [Drugs against the neglected diseases].
Fretheim A; Guerin PJ
Tidsskr Nor Laegeforen; 2002 Nov; 122(28):2691. PubMed ID: 12523085
[No Abstract] [Full Text] [Related]
2. Drug development for neglected diseases - the trouble with FDA review vouchers.
Kesselheim AS
N Engl J Med; 2008 Nov; 359(19):1981-3. PubMed ID: 18987367
[No Abstract] [Full Text] [Related]
3. Epilogue: New drugs for neglected diseases.
Pogge T; Hollis A
Camb Q Healthc Ethics; 2011 Apr; 20(2):329-34. PubMed ID: 21435308
[No Abstract] [Full Text] [Related]
4. [Pharmacotherapy of parasitic and tropical diseases in Japan].
Maruyama H; Kimura M
Nihon Rinsho; 2012 Dec; 70(12):2205-17. PubMed ID: 23259398
[TBL] [Abstract][Full Text] [Related]
5. WHO and Sanofi-Aventis expand programme to fight neglected tropical diseases.
Indian J Med Sci; 2006 Nov; 60(11):487. PubMed ID: 17121207
[No Abstract] [Full Text] [Related]
6. Filling the pipeline for neglected diseases: creation of a medicinal chemistry-centric international drug discovery institute [iDDi].
Kozikowski AP; Reitz AB
Drug Discov Today; 2008 Feb; 13(3-4):97-8. PubMed ID: 18275906
[No Abstract] [Full Text] [Related]
7. Drug discovery and development for neglected parasitic diseases.
Renslo AR; McKerrow JH
Nat Chem Biol; 2006 Dec; 2(12):701-10. PubMed ID: 17108988
[TBL] [Abstract][Full Text] [Related]
8. [The need to advance pharmaceutical innovation in tropical medicine: from incantations to reality].
Ambroise-Thomas P
Med Trop (Mars); 1997; 57(1):33-4. PubMed ID: 9289605
[No Abstract] [Full Text] [Related]
9. Ethical issues in funding research and development of drugs for neglected tropical diseases.
Oprea L; Braunack-Mayer A; Gericke CA
J Med Ethics; 2009 May; 35(5):310-4. PubMed ID: 19407037
[TBL] [Abstract][Full Text] [Related]
10. [Development of special research programs in the field of parasitic diseases and tropical diseases].
Martinotti MG; Landolfo S
G Batteriol Virol Immunol; 1981; 74(1-6):181-8. PubMed ID: 7308624
[No Abstract] [Full Text] [Related]
11. Infectious diseases. Tackling neglected diseases could offer more bang for the buck.
Vogel G
Science; 2006 Feb; 311(5761):592-3. PubMed ID: 16456044
[No Abstract] [Full Text] [Related]
12. FDA review vouchers.
Moe J; Grabowski H; Ridley D
N Engl J Med; 2009 Feb; 360(8):837; author reply 837-8. PubMed ID: 19228632
[No Abstract] [Full Text] [Related]
13. [The Novartis Institute for Tropical diseases. Hopes concerning therapies against dengue and tuberculosis].
Einecke D
MMW Fortschr Med; 2007 Apr; 149(16):11-2. PubMed ID: 17953256
[No Abstract] [Full Text] [Related]
14. Problems with old diseases related to social and pharmaceutical industry situations.
Neu HC
Bull N Y Acad Med; 1988; 64(6):456-61. PubMed ID: 3233432
[No Abstract] [Full Text] [Related]
15. [Special Program for Research and Training in Tropical Disease. I].
Nikolaevskiĭ GP; Voĭskunskaia NI; Soprunov FF
Med Parazitol (Mosk); 1981; 50(4):14-20. PubMed ID: 7278807
[No Abstract] [Full Text] [Related]
16. Orphan drug legislation: lessons for neglected tropical diseases.
Villa S; Compagni A; Reich MR
Int J Health Plann Manage; 2009; 24(1):27-42. PubMed ID: 18435430
[TBL] [Abstract][Full Text] [Related]
17. New non-profit organization will support research to combat neglected diseases.
Walgate R
Bull World Health Organ; 2002; 80(10):842-3. PubMed ID: 12471410
[No Abstract] [Full Text] [Related]
18. Fighting the parasites of poverty: public research, private industry, and tropical diseases.
Godal T
Science; 1994 Jun; 264(5167):1864-6. PubMed ID: 8009212
[No Abstract] [Full Text] [Related]
19. Industry continues dabbling with open innovation models.
Sheridan C
Nat Biotechnol; 2011 Dec; 29(12):1063-5. PubMed ID: 22158347
[No Abstract] [Full Text] [Related]
20. New drugs for old diseases.
Goodwin LG
Trans R Soc Trop Med Hyg; 1980; 74(1):1-7. PubMed ID: 7001681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
